Results 111 to 120 of about 7,457,680 (317)
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
In extraordinary water situations, art. 58 of the consolidated version of the Act on Waters (TRLA, in Spanish), entitles the Government to issue regulations of necessity. According to the general theory about necessity, the aforementioned regulations can
Belén Marina Jalvo
doaj +1 more source
Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici +8 more
wiley +1 more source
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert +13 more
wiley +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
Exceptional sets and Hilbert–Schmidt composition operators
Let \(D\) be the unit disk in the complex plane and \(\varphi\) be an analytic map from \(D\) to itself. Let \(E_\varphi = \{ e^{i\theta} \in \partial D : | \varphi(e^{i\theta})| = 1 \} \) be the exceptional set and the composition operator \(C_\varphi : {\mathcal{H}}(D) \rightarrow {\mathcal{H}}(D)\) be defined as \(C_\varphi f = f \circ \varphi ...
Gallardo-Gutiérrez, Eva A. +1 more
openaire +1 more source
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Local cohomology along exceptional sets
Let \({\mathcal F}\) be a locally free coherent sheaf of a reduced complex space of dimension n. Let E be a closed analytic subset. To compute local cohomology along E one has natural homomorphisms \(H^ i_ E(X;{\mathcal F})\to \lim_{\to}Ext^ i_{{\mathcal O}_ X}({\mathcal O}_ X/{\mathcal J}^ m,{\mathcal F})\) and duality homomorphisms \(H^ i_ E(X ...
openaire +1 more source

